{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462094438
| IUPAC_name = 2-(Dibutylamino)-1-[(9''Z'')-2,7-dichloro-9-(4-chlorobenzylidene)-9''H''-fluoren-4-yl]ethanol
| image = Lumefantrine.svg
| width = 200

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|lumefantrine}}
| MedlinePlus = a609024
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US_comment = C
| legal_status = 
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 82186-77-4
| ATC_prefix = P01
| ATC_suffix = BF01
| ATC_supplemental = (combination with [[artemether]])
| PubChem = 6437380
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06708
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4941944
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F38R0JR742
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03821
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 156095
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 38827

<!--Chemical data-->
| C = 30 | H = 32 | Cl = 3 | N = 1 | O = 1 
| molecular_weight = 528.939 g/mol
| smiles = Clc1ccc(cc1)\C=C3\c4c(c2c(cc(Cl)cc23)C(O)CN(CCCC)CCCC)ccc(Cl)c4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DYLGFOYVTXJFJP-MYYYXRDXSA-N
}}

'''Lumefantrine''' (or '''benflumetol''') is an [[antimalarial drug]]. It is only used in [[Artemether/lumefantrine|combination]] with [[artemether]]. The term "co-artemether" is sometimes used to describe this combination.<ref name="pmid17291911">{{cite journal |vauthors=Toovey S, Jamieson A, Nettleton G |title = Successful co-artemether (artemether-lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique |journal = Travel medicine and infectious disease |volume = 1 |issue = 3 |pages = 177–9 |year = 2003 |pmid = 17291911 |doi = 10.1016/j.tmaid.2003.09.002}}</ref> Lumefantrine has a much longer half-life compared to artemether and so is therefore thought to clear any residual parasites that remain after combination treatment.<ref name="Whitevan Vugt1999">{{cite journal|last1=White|first1=Nicholas J.|last2=van Vugt|first2=Michele|last3=Ezzet|first3=Farkad|title=Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine|journal=Clinical Pharmacokinetics|volume=37|issue=2|year=1999|pages=105–125|issn=0312-5963|doi=10.2165/00003088-199937020-00002}}</ref>

Lumefantrine, along with [[pyronaridine]] and [[naphtoquine]], were synthesized in course of the [[Project 523]] antimalaria drug research initiated in 1967; these compounds are all used in combination antimalaria therapies.<ref name="cui">{{cite journal |last1 = Cui |first1 = Liwang |last2 = Su |first2 = Xin-zhuan  |title = Discovery, mechanisms of action and combination therapy of artemisinin |journal = [[Expert Review of Anti-infective Therapy]] |year = 2009 |volume = 7 |issue = 8 |pages = 999–1013 |doi = 10.1586/eri.09.68  |pmid = 19803708 |pmc = 2778258}}</ref><ref>http://aac.asm.org/content/56/5/2465.full</ref><ref>{{cite journal | pmc = 4280121 | pmid=25549086 | doi=10.1371/journal.pmed.1001773 | volume=11 | title=Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial | year=2014 | journal=PLoS Med. | pages=e1001773 | last1 = Laman | first1 = M | last2 = Moore | first2 = BR | last3 = Benjamin | first3 = JM | last4 = Yadi | first4 = G | last5 = Bona | first5 = C | last6 = Warrel | first6 = J | last7 = Kattenberg | first7 = JH | last8 = Koleala | first8 = T | last9 = Manning | first9 = L | last10 = Kasian | first10 = B | last11 = Robinson | first11 = LJ | last12 = Sambale | first12 = N | last13 = Lorry | first13 = L | last14 = Karl | first14 = S | last15 = Davis | first15 = WA | last16 = Rosanas-Urgell | first16 = A | last17 = Mueller | first17 = I | last18 = Siba | first18 = PM | last19 = Betuela | first19 = I | last20 = Davis | first20 = TM}}</ref>

==See also==
* [[Artemether/lumefantrine]]
* [[Halofantrine]]

== References ==
{{Reflist}}

{{Antimalarials}}

[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Antimalarial agents]]
[[Category:Chinese discoveries]]
[[Category:Chloroarenes]]
[[Category:Fluorenes]]

{{antiinfective-drug-stub}}